Deferasirox-induced urticarial vasculitis in a patient with myelodysplastic syndrome
An. bras. dermatol; 92 (5,supl.1), 2017
Abstract Deferasirox is an iron chelator agent used in the treatment of diseases with iron overload, such as thalassemia and myelodysplastic syndrome. Although the majority of adverse reactions of deferasirox involve gastrointestinal symptoms and increase in serum creatinine and transaminases, skin rashe...
Benzoatos/efectos adversos, Biopsia, Deferasirox, Erupciones por Medicamentos/etiología, Erupciones por Medicamentos/patología, Quelantes del Hierro/efectos adversos, Síndromes Mielodisplásicos/tratamiento farmacológico, Triazoles/efectos adversos, Urticaria/inducido químicamente, Urticaria/patología, Vasculitis/inducido químicamente, Vasculitis/patología